← Leaderboards
Laxmikant S Deshpande
Virginia Commonwealth University
$2,492,887
Attributed
$2,642,885
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $953.2K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,342,888 · 3
ATSDR$299,997 · 1
By mechanism
UG3$1,069,767 · 1
U01$919,902 · 2
UH3$653,216 · 1
Top collaborators
- Kelly Graham Gwathmey1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Robert Delorenzo$15,322,261
- Travis Joseph Chiarelli$148,460
Others in their field
Other Emerging Leaders on “Mossy Fiber”
- Padmavathi Sundaram Patel · Massachusetts General Hospital$2,943,609
- Sergi Simo · University Of California At Davis$1,717,190
- Adam Hantman · Univ Of North Carolina Chapel Hill$1,675,892
- Qian Sun · Case Western Reserve University$1,632,321
- Karl Daniel Murray · University Of California At Davis$1,050,184
- James Gerard Heys · University Of Utah$863,139
Research focus
Mossy FiberOrganophosphatesHypertensionMortalityNeuronsNeuroprotectionChemical ThreatFluorophosphateIntramuscularMorbidity - Disease RateChronicNerve AgentBehavioralCholinergicAcuteBrainEffective TherapyExposure ToImpaired CognitionInsightIntramuscular InjectionsMidazolamAtropinePesticides
Grant awards (5)
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus$653,216
UH3 · FY2025 · NS · contact PI
Detection of novel environmental risk factors in the recently identified ALS clusters in Central Virginia$299,997
U01 · FY2025 · TS · contact PI
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus$526,392
UG3 · FY2024 · NS · contact PI
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus$543,375
UG3 · FY2023 · NS · contact PI
Novel Counteract Agents To Reduce Mortality And Morbidity Following Organophosphate Status Epilepticus$619,905
U01 · FY2021 · NS · contact PI